Educational guide
Atrium Therapeutics (RNA) Price Targets
(Delayed Data from NSDQ) $13.20 USD 13.20 180,676 -0.28 (-2.08%) Updated Aug 21, 2026 04:00 PM ET After-Market: $13.25 +0.05 (0.38%) 7:58 PM ET This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. H
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
$13.20 USD
13.20
180,676
-0.28 (-2.08%)
Updated Aug 21, 2026 04:00 PM ET
After-Market: $13.25 +0.05 (0.38%) 7:58 PM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 23.80% |
| 2 | Buy | 18.13% |
| 3 | Hold | 10.19% |
| 4 | Sell | 5.73% |
| 5 | Strong Sell | 3.17% |
| S&P | 500 | 11.53% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
4-Sell of 5 4
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
- Value Score A
- Growth Score A
- Momentum Score A
- VGM Score A
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
D Value C Growth A Momentum D VGM
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Atrium Therapeutics (RNA) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $25.00 | $25.00 | $25.00 | 85.46% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by four analysts, the average price target for Atrium Therapeutics comes to $25.00. The forecasts range from a low of $25.00 to a high of $25.00. The average price target represents an increase of 85.46% from the last closing price of $13.48.
Analyst Price Targets (4)
Last Close 13.48
Average 25.00 85.46% Upside Low 25.00 85.46% Upside High 25.00 85.46% Upside
Broker Rating
Atrium Therapeutics currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on four recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
| 3 Months Ago | 2 Months Ago | 1 Month Ago | 1 Week Ago | Today | |
|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.00 | 1.50 | 1.50 | 1.40 | 1.40 |
Latest Forecasts
Filter By: Select Date Recommendation Upside/Downside1. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations.
2. Zacks sources identified analysts from public media. The identified analyst information displayed on this page is not provided to Zacks by brokerage firms directly.